Outcome of Patients with Chronic Myeloid Leukemia After Allogeneic Stem Cell Transplantation in Europe; Data From the EUTOS for CML Registry

被引：0

作者：

Saussele, Susanne ^{[1
]}

Hoffmann, Verena ^{[2
]}

Lindoerfer, Doris ^{[2
]}

Hochhaus, Andreas ^{[3
]}

Cervantes, Francisco ^{[4
]}

Ossenkoppele, Gert ^{[5
]}

Hjorth-Hansen, Henrik ^{[6
]}

O'Brien, Steve ^{[7
]}

Mayer, Jiri ^{[8
]}

Indrak, Karel ^{[9
]}

Hellmann, Andrzej ^{[10
]}

Colita, Adriana

Turkina, Anna ^{[11
]}

Zaritskey, Andrey ^{[12
]}

Luis Steegmann, Juan ^{[13
]}

Marin, David ^{[14
]}

Pfirrmann, Markus ^{[2
]}

Baccarani, Michele ^{[15
]}

Guilhot, Joelle ^{[16
]}

Hasford, Joerg ^{[2
]}

Piccolo, Carmen ^{[17
]}

Simonsson, Bengt ^{[18
]}

Hehlmann, Ruediger ^{[1
]}

Rosti, Gianantonio ^{[19
]}

机构：

[1] Univ Heidelberg, Med Fak Mannheim, Med Klin 3, D-6800 Mannheim, Germany

[2] Univ Munich, Inst Med Informat & Biometry, Munich, Germany

[3] Univ Klinikum Jena, Jena, Germany

[4] Hosp Clin Barcelona, Dept Hematol, Barcelona, Spain

[5] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands

[6] Norwegian Univ Sci & Technol, Trondheim, Norway

[7] Newcastle Univ, Dept Hematol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England

[8] Univ Hosp Brno, Dept Haematol Oncol, Brno, Czech Republic

[9] Univ Hosp, Dept Hematooncol, Olomouc, Czech Republic

[10] Med Univ Gdansk, Dept Hematol & Transplantol, Gdansk, Poland

[11] Natl Res Ctr Hematol, Moscow, Russia

[12] VA Almazov, Ctr Heart Blood & Endocrinol, St Petersburg, Russia

[13] Hosp Univ Princesa, Dept Hematol, Madrid, Spain

[14] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Hematol, London, England

[15] Univ Bologna, Dept Hematol Oncol L&A Seragnoli, Bologna, Italy

[16] CHU Poitiers, INSERM, CIC 0802, Poitiers, France

[17] Novartis GmbH, Origgio, Italy

[18] Univ Uppsala Hosp, Dept Med, Uppsala, Sweden

[19] Univ Bologna, Dept Hematol & Oncol L&A Seragnoli, Bologna, Italy

来源：

BLOOD | 2011年 / 118卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：733 / 734

页数：2

共 50 条

[41] Imatinib (Glivec) therapy in advanced chronic myeloid leukemia (CML) patients in combination with allogeneic peripheral blood stem cell transplantation (PBSCT).
le Coutre, P
Massenkeil, G
Zschieschang, P
Genvresse, I
Schwarz, M
Reich, G
Körner, H
Dörken, B
Arnold, R
BLOOD, 2002, 100 (11) : 428A - 429A
[42] Outcome of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukaemia
Devillier, R.
Crocchiolo, R.
Etienne, A.
Prebet, T.
Charbonnier, A.
Fuerst, S.
El Cheikh, J.
D'Incan, E.
Rey, J.
Faucher, C.
Blaise, D.
Vey, N.
BONE MARROW TRANSPLANTATION, 2012, 47 : S100 - S100
[43] Outcome of Chronic Lymphocytic Leukemia (CLL) Patients That Failed Allogeneic Stem Cell Transplantation
Benjamini, Ohad
Rozovski, Uri
Jain, Preetesh
Wierda, William G.
O'Brien, Susan
Burger, Jan
Ferrajoll, Alessandra
Faderl, Stefan
Shpall, Elizabeth
Hosing, Chitra
Khouri, Issa F.
Champlin, Richard
Keating, Michael J.
Estrov, Zeev
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 : S130 - S131
[44] Outcome Of Chronic Lymphocytic Leukemia (CLL) Patients That Failed Allogeneic Stem Cell Transplantation
Benjamini, Ohad
Rozovski, Uri
Jain, Preetesh
Wierda, William G.
O'Brien, Susan
Burger, Jan A.
Ferrajoli, Alessandra
Faderl, Stefan H.
Shpall, Elizabeth J.
Hosing, Chitra M.
Khouri, Issa F.
Champlin, Richard E.
Keating, Michael J.
Estrov, Zeev
BLOOD, 2013, 122 (21)
[45] Relapse of chronic myeloid leukaemia after allogeneic stem cell transplantation:: outcome and prognostic factors
Martínez, C
de Soria, VGG
Tomás, JF
Parody, R
Sureda, A
Sanz, G
Cañizo, C
Díez, JL
Boqué, C
BONE MARROW TRANSPLANTATION, 2004, 33 : S61 - S61
[46] Impact of Tyrosine Kinase Inhibitor (TKI) in Chronic Myeloid Leukemia (CML) Relapsing After T Cell Depleted Allogeneic Stem Cell Transplantation (SCT)
Ito, Sawa
Battiwalla, Minoo
Koklanaris, Eleftheria K.
Superata, Jeanine
Childs, Richard
Barrett, John
BLOOD, 2011, 118 (21) : 1188 - 1189
[47] Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Middeke, Jan M.
Fang, Min
Cornelissen, Jan J.
Mohr, Brigitte
Appelbaum, Frederick R.
Stadler, Michael
Sanz, Jaime
Baurmann, Herrad
Bug, Gesine
Schaefer-Eckart, Kerstin
Hegenbart, Ute
Bochtler, Tilmann
Roellig, Christoph
Stoelzel, Friedrich
Walter, Roland B.
Ehninger, Gerhard
Bornhaeuser, Martin
Loewenberg, Bob
Schetelig, Johannes
BLOOD, 2014, 123 (19) : 2960 - 2967
[48] OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION IN PEDIATRIC PATIENTS WITH ACUTE MYELOID LEUKEMIA AFTER CONDITIONING WITH BUSULFAN, CYCLOPHOSPHAMIDE, AND ETOPOSIDE
Ayas, Mouhab
Belgaumi, Assim
Al-Seraihy, Amal
Al-Jefri, Abdullah
Al-Ahmari, Ali
Al-Mahr, Mohammed
Khairy, Ashraf
Markiz, Samer
El-Soth, Hassan
PEDIATRIC BLOOD & CANCER, 2011, 57 (05) : 816 - 816
[49] Utility of a prognostic scoring system for allogeneic stem cell transplantation in patients with chronic myeloid leukemia
Qazilbash, MH
Devetten, MP
Abraham, J
Lynch, JP
Beall, CL
Weisenborn, R
Bunner, P
Ericson, SG
ACTA HAEMATOLOGICA, 2003, 109 (03) : 119 - 123
[50] Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia
Pavletic, ZS
Arrowsmith, ER
Bierman, PJ
Goodman, SA
Vose, JM
Tarantolo, SR
Stein, RS
Bociek, G
Greer, JP
Wu, CD
Kollath, JP
Weisenburger, DD
Kessinger, A
Wolff, SN
Armitage, JO
Bishop, MR
BONE MARROW TRANSPLANTATION, 2000, 25 (07) : 717 - 722

← 1 2 3 4 5 →